Cargando…

TOCILIZUMAB- A TREATMENT OPTION FOR TORSADES DE POINTES IN COVID-19 PATIENTS

Detalles Bibliográficos
Autores principales: Anwaar, Muhammad Faraz, Kazmi, Sana, Khosla, Jagjit, Gujju, Veena, Agarwal, Siddharth, Krishan, Satyam, Khan, Jehanzeb, Akkus, Nuri Ilker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Cardiology Foundation. Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982942/
http://dx.doi.org/10.1016/S0735-1097(23)04354-1
_version_ 1784900437869068288
author Anwaar, Muhammad Faraz
Kazmi, Sana
Khosla, Jagjit
Gujju, Veena
Agarwal, Siddharth
Krishan, Satyam
Khan, Jehanzeb
Akkus, Nuri Ilker
author_facet Anwaar, Muhammad Faraz
Kazmi, Sana
Khosla, Jagjit
Gujju, Veena
Agarwal, Siddharth
Krishan, Satyam
Khan, Jehanzeb
Akkus, Nuri Ilker
author_sort Anwaar, Muhammad Faraz
collection PubMed
description
format Online
Article
Text
id pubmed-9982942
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American College of Cardiology Foundation. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-99829422023-03-03 TOCILIZUMAB- A TREATMENT OPTION FOR TORSADES DE POINTES IN COVID-19 PATIENTS Anwaar, Muhammad Faraz Kazmi, Sana Khosla, Jagjit Gujju, Veena Agarwal, Siddharth Krishan, Satyam Khan, Jehanzeb Akkus, Nuri Ilker J Am Coll Cardiol Complex Clinical Cases American College of Cardiology Foundation. Published by Elsevier Inc. 2023-03-07 2023-03-03 /pmc/articles/PMC9982942/ http://dx.doi.org/10.1016/S0735-1097(23)04354-1 Text en © 2023 American College of Cardiology Foundation Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Complex Clinical Cases
Anwaar, Muhammad Faraz
Kazmi, Sana
Khosla, Jagjit
Gujju, Veena
Agarwal, Siddharth
Krishan, Satyam
Khan, Jehanzeb
Akkus, Nuri Ilker
TOCILIZUMAB- A TREATMENT OPTION FOR TORSADES DE POINTES IN COVID-19 PATIENTS
title TOCILIZUMAB- A TREATMENT OPTION FOR TORSADES DE POINTES IN COVID-19 PATIENTS
title_full TOCILIZUMAB- A TREATMENT OPTION FOR TORSADES DE POINTES IN COVID-19 PATIENTS
title_fullStr TOCILIZUMAB- A TREATMENT OPTION FOR TORSADES DE POINTES IN COVID-19 PATIENTS
title_full_unstemmed TOCILIZUMAB- A TREATMENT OPTION FOR TORSADES DE POINTES IN COVID-19 PATIENTS
title_short TOCILIZUMAB- A TREATMENT OPTION FOR TORSADES DE POINTES IN COVID-19 PATIENTS
title_sort tocilizumab- a treatment option for torsades de pointes in covid-19 patients
topic Complex Clinical Cases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982942/
http://dx.doi.org/10.1016/S0735-1097(23)04354-1
work_keys_str_mv AT anwaarmuhammadfaraz tocilizumabatreatmentoptionfortorsadesdepointesincovid19patients
AT kazmisana tocilizumabatreatmentoptionfortorsadesdepointesincovid19patients
AT khoslajagjit tocilizumabatreatmentoptionfortorsadesdepointesincovid19patients
AT gujjuveena tocilizumabatreatmentoptionfortorsadesdepointesincovid19patients
AT agarwalsiddharth tocilizumabatreatmentoptionfortorsadesdepointesincovid19patients
AT krishansatyam tocilizumabatreatmentoptionfortorsadesdepointesincovid19patients
AT khanjehanzeb tocilizumabatreatmentoptionfortorsadesdepointesincovid19patients
AT akkusnuriilker tocilizumabatreatmentoptionfortorsadesdepointesincovid19patients